Key result
Amiodarone therapy was associated with severe pulmonary toxicity in a single patient, confirmed by open lung biopsy with light and electron microscopy.
Case Report (n=1)
Highlights a severe case of amiodarone-induced pulmonary toxicity confirmed by biopsy, emphasizing the need to monitor for this serious adverse reaction.
Answers are grounded in this paper and cite their sources.
Amiodarone pulmonary toxicity warrants vigilance; single case report leaves incidence and risk quantification open.
Amiodarone is an iodinated benzofuran derivative that represents a new and extremely effective therapy for certain life-threatening refractory cardiac arrgythmia. There are numerous side effects associated with amiodarone therapy, including corneal microdeposits. Skin reactions and others. Pulmonary toxicity, however, represents the most serious adverse reaction limiting the clinical effecacy of this antidysrhythmic drug. Recently, we experienced a case of amiodarone-induced pulmonary toxicity confirmed by open lung biopsy with light-and electron-microscopy. So, we report a case of amiodarone-induced pulmonary toxicity with a literature review.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (1995) conducted a case report in Amiodarone-induced pulmonary toxicity (n=1). Amiodarone was evaluated on Pulmonary toxicity. Amiodarone therapy was associated with severe pulmonary toxicity in a single patient, confirmed by open lung biopsy with light and electron microscopy.
Synapse has enriched 10 related papers. Consider them for comparative context: